Sanyou Biopharmaceuticals Co., Ltd. is a world-leading high-tech biotechnology enterprise focusing on R&D and services of innovative biological drugs. Sanyou is committed to establishing an internationally leading high-quality, high-throughput and integrated R&D and value transformation platform for innovative biological drugs, constructing a business ecosystem including therapy, R&D and diagnostic products and services, and cooperating with global biopharmaceutical, diagnostic and drug R&D companies to make a new progress in the diagnosis and treatment of human diseases. Sanyou has established an integrated innovative biological drug R&D laboratory of twenty thousand square meters with advanced facilities and the R&D laboratory is comprised of 10 major functional modules and more than 50 core technological platforms, which are featured by a series of Super-Trillion phage display antibody libraries and integrated platforms covering innovative biological drug discovery, innovative biological drug optimization, production cell line construction, upstream and downstream process development, preclinical R&D and industrial development, etc. Sanyou has built a business system that integrates "differentiated CRO, innovative CPO and characteristic CRS”, and keeps launching new technologies, new products, new services, and new scenarios base on the principle of innovation, outstanding, reliability. Friendly business collaborations have been established with more than 600 pharmaceutical companies, drug R&D institutions and diagnostics companies worldwide.